ReviewThe Journal of allergy and clinical immunology2011
Advancing asthma care: the glass is only half full!
Review in The Journal of allergy and clinical immunology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
24 citing papers in PubMed, 72 citations in OpenAlex.
- Individualized therapy for persistent asthma in young children.The Journal of allergy and clinical immunology · 2016Trial
- Experimentally manipulated sleep duration in adolescents with asthma: Feasibility and preliminary findings.Pediatric pulmonology · 2015Trial
- Deletion of Miro1 in airway club cells potentiates allergic asthma phenotypes.Frontiers in allergy · 2023Article
- Asthma mortality among children and adolescents in China, 2008-2018.World journal of pediatrics : WJP · 2022Article
- Trends and determinants of Emergency Room admissions for asthma: A retrospective evaluation in Northeast Italy.The World Allergy Organization journal · 2019Article
- Oxidative Stress in the Lung - The Essential Paradox.Current opinion in toxicology · 2018Article
- Corticosteroids inhibit anti-IgE activities of specialized proresolving mediators on B cells from asthma patients.JCI insight · 2017Article
- Recent developments in the role of reactive oxygen species in allergic asthma.Journal of thoracic disease · 2017Review
- Changing Trends in Asthma Prevalence Among Children.Pediatrics · 2016Article
- Pharmacodynamic genome-wide association study identifies new responsive loci for glucocorticoid intervention in asthma.The pharmacogenomics journal · 2015Article
- Anti-allergic properties of curine, a bisbenzylisoquinoline alkaloid.Molecules (Basel, Switzerland) · 2015Review
- The WEB-based Asthma Control: an intriguing connection or a dangerous hazard?Asthma research and practice · 2015Review
- Level of asthma control and its relationship with medication use in asthma patients in Brazil.Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia · 2014Article
- Poor asthma control in obese children may be overestimated because of enhanced perception of dyspnea.The journal of allergy and clinical immunology. In practice · 2013Article
- International consensus on (ICON) pediatric asthma.Allergy · 2012Article
- The practical understanding and treatment of asthma.Clinical reviews in allergy & immunology · 2012Article
- Glutathione redox control of asthma: from molecular mechanisms to therapeutic opportunities.Antioxidants & redox signaling · 2012Review
- Severe asthma in childhood: recent advances in phenotyping and pathogenesis.Current opinion in allergy and clinical immunology · 2012Review
- Evidence-based health: necessary but not sufficient.Preventing chronic disease · 2012Article
- Is it time to revise the asthma guidelines?The Journal of allergy and clinical immunology · 2011Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author at 1 institution in 1 country.
Funding
Abstract
Over the past 20 years, there has been a concerted effort in the United States to reduce morbidity related to chronic disease, including asthma. Attention was initially directed toward asthma in response to the recognition that asthma mortality was increasing and that the burden of disease was significant. These efforts to address asthma mortality led to many new initiatives to develop clinical practice guidelines, implement the asthma guidelines into clinical practice, conduct research to fill the gaps in the guidelines, and continuously revise the asthma guidelines as more information became available. An assessment of our progress shows significant accomplishments in relation to reducing asthma mortality and hospitalizations. Consequently, we are now at a crossroads in asthma care. Although we have recognized some remarkable accomplishments in reducing asthma mortality and morbidity, the availability of new tools to monitor disease activity, including biomarkers and epigenetic markers, along with information technology systems to monitor asthma control hold some promise in identifying gaps in disease management. These advances should prompt the evolution of new strategies and new treatments to further reduce disease burden. It now becomes imperative to continue a focus on ways to further reduce the burden of asthma and prevent its onset.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.